HONG TAO ZHANG, MD
Psychiatric in Far Rockaway, NY

License number
New York 218227
Category
Psychiatric
Type
Psychiatry
Address
Address 2
327 Beach 19 St, Far Rockaway, NY 11691
1066 Jassamine Way, West Fort Lee, NJ 07024
Phone
(718) 869-7000
(201) 886-9673

Personal information

See more information about HONG TAO ZHANG at radaris.com
Name
Address
Phone
Hong Zhang, age 81
3825 Woodside Ave, Woodside, NY 11377
(718) 426-3695
Hong Zhang
380 Rector Pl APT 6A, New York, NY 10280
Hong Zhang, age 67
3 Dallenbach Ln, East Brunswick, NJ 08816
(732) 613-1349
Hong Zhang, age 77
42 Speare Rd, Woodstock, NY 12498
(845) 679-5865
Hong Zhang
4334 Union St APT 6J, Flushing, NY 11355
(718) 353-7985

Organization information

See more information about HONG TAO ZHANG at bizstanding.com

Dr. Hong Tao Zhang, MD

327 Bch 19 St, Far Rockaway, NY 11691

Industry:
Medical Doctor's Office
Medical Doctors:
Hong T. Zhang (Medical Doctor, Principal),Jin Zhang (Osteopathy),Albert Heng-Yao Chang (Medical Doctor)

Professional information

Hong Tao Zhang Photo 1

Dr. Hong Tao Zhang, Orangeburg NY - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Psychiatry)
Address:
140 Old Orangeburg Rd SUITE 60, Orangeburg 10962
(845) 680-7906 (Phone), (845) 680-5506 (Fax)
327 Beach 19Th St, Far Rockaway 11691
(718) 869-7000 (Phone)
Certifications:
Psychiatry, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
140 Old Orangeburg Rd SUITE 60, Orangeburg 10962
327 Beach 19Th St, Far Rockaway 11691
Saint John's Episcopal Hospital at South Shore
327 Beach 19Th St, Far Rockaway 11691


Hong Zhang Photo 2

Dna Encoding Snorf138 And Uses Thereof

US Patent:
2004021, Oct 28, 2004
Filed:
Oct 3, 2003
Appl. No.:
10/679185
Inventors:
Roman Artymyshyn - Flemington NJ, US
Liliana Delgado - Rochelle Park NJ, US
Pierre Vaysse - Franklin Lakes NJ, US
Hong Zhang - Fort Lee NJ, US
Weinong Guo - Marietta GA, US
Assignee:
Synaptic Pharmaceutical Corporation
International Classification:
G01N033/53, G01N033/567
US Classification:
435/007200
Abstract:
This invention provides methods of treating an abnormality that is linked to the activity of the mammalian SNORF138 receptor, as well as methods of determining binding of compounds to the mammalian SNORF138 receptor, methods of identifying agonists and antagonists of the SNORF138 receptor, and agonists and antagonists so identified.